Breakout stock Trading Day Trading

Technically up Trend Stocks for Portfolio | Day | Swing Trading with support | resistance | stock research

MSFT	Microsoft Co
Sector Software Recommendations Buy Buy Near 21.31 Stop Loss 20.91 Posted Date 6/5/2009 1:32:46 AM First Resistance 22.53 Second Resistance 23.50 Third Resistance 26.67 First Support 20.91 Second Support 19.54 Comments 6/4/2009 12:27:56 PM Technical stock research Yesterday Microsoft (MSFT) given a breakout of reverse head and shoulder pattern beside that ADX also indicating up word move for Microsoft (MSFT), rate of change (ROC) got upward momentum with increasing relative price index (RSI). Stock investing with chart pattern Head and solder is a best chaise and as per technical view Microsoft (MSFT) in a short term up trend. You can use Microsoft for day trading also. As per head and shoulder theory for Microsoft our up side target is $26.67. So built position with target $26.67 and consider base line as a stop loss ($20.91) [video] The Next Big Tech Targets (at TheStreet.com) (Thu, 29 Jul 2010 11:00:00 Etc/GMT) [video] Google searches for growth (at Fortune) (Thu, 29 Jul 2010 11:00:00 Etc/GMT) While still dominant in search, and gaining in mobile, Google's stock has been relatively flat for several years. French tech firms up targets; global picture mixed (at Reuters) (Thu, 29 Jul 2010 10:42:14 Etc/GMT) Tech Feud: Informatica vs. Microsoft (at TheStreet.com) (Thu, 29 Jul 2010 10:30:00 Etc/GMT) Data-integrator Informatica is rallying but boring, old Microsoft outshines it in nearly all metrics. Microsoft hosts annual financial analyst meeting (AP) (Thu, 29 Jul 2010 10:28:30 Etc/GMT) Analysts will be looking for clues about the future of Microsoft Corp.'s mobile and online businesses and its strategy for Windows-based tablet computers at an annual meeting with the software maker on Thursday.
ARRS	ARRIS Group Inc Com
Sector Technology : Communications Equipment Recommendations Buy Buy Near 7.32 Stop Loss 6.62 Posted Date 1/1/2009 12:00:00 AM First Resistance 8.77 Second Resistance 9.62 Third Resistance 9.75 First Support 7.32 Second Support 7.19 Comments 1/1/2009 9:03:06 PM ARRIS Group Inc Com (ARRS), yesterday announced that its Advanced Advertising Manager solution has successfully interconnected with systems of several leading Advanced Advertising Decision Service and Campaign Manager providers at its labs in Beaverton and stock given a breackout with high volume. Again given a buy signal with rising moving average. Stochastic, rate of change (ROC) and ADX also given a buy signal As per technical analysis, stock analysis and fundamental research ARRIS Group Inc Com (ARRS) stock looks good candidate for breakout stock investing as well as you can add in portfolio investment. Recently stock given a breakout with rising moving average and also stochastic and Rate of change (ROC) given a buy signal. ARRIS Group Inc Com (ARRS) stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to stock market and economic condition keep tight stop loss on all position. You can buy this stock near $7.32 10/16/2005 12:00:00 AM Sell sort at 12 with 12.47 stop loss UPDATE - Arris posts weak Q2 results, Q3 outlook; shares fall (at Reuters) (Wed, 28 Jul 2010 21:30:47 Etc/GMT) ARRIS Group, Inc. Earnings Call scheduled for 5:00 pm ET today (CCBN) (Wed, 28 Jul 2010 21:00:00 Etc/GMT) Arris Shrs Swoon As Q2 Misses; Q3 Outlook Falls Short Of Ests (at Barron's Online) (Wed, 28 Jul 2010 20:34:53 Etc/GMT) ARRIS GROUP INC Files SEC form 8-K, Results of Operations and Financial Condition (EDGAR Online) (Wed, 28 Jul 2010 20:13:54 Etc/GMT) ARRIS Announces Preliminary and Unaudited Second Quarter 2010 Results (PR Newswire) (Wed, 28 Jul 2010 20:00:00 Etc/GMT) ARRIS Group, Inc. , a global technology leader in the development of advanced cable telephony, next generation high-speed data, demand driven video solutions, operations software and broadband access equipment, today announced preliminary and unaudited financial results for the second quarter 2010.
AHL	Aspen Insurance Holdings Limited
Sector Financial : Insurance Recommendations Buy Buy Near 22.93 Stop Loss 22.15 Posted Date 1/1/2009 12:00:00 AM First Resistance 24.34 Second Resistance 27.50 Third Resistance 28.00 First Support 22.93 Second Support 22.56 Comments 1/1/2009 9:04:46 PM Aspen Insurance Holdings Limited (AHL) recently announced that its subsideary, Aspen Insurance UK Limited, authorized by the Regulation Authority to operate as a branch insurer to underwrite general insurance business in Australia and also announced that A.M. Best has affirmed the AAA financial strength ratings of Aspen Bermuda subsideary, Aspen Insurance Limited and its UK subsideary, Aspen Insurance UK Limited. Again given a buy signal with rising moving average. Stochastic, rate of change (ROC) and ADX also given a buy signal As per technical analysis, stock analysis and fundamental research this stock looks good candidate for breakout stock investing as well as you can add in portfolio investment. Aspen Insurance Holdings Limited (AHL) stock given a breakout with high volume and rising moving average and also stochastic & Rate of change ROC) given a buy signal. Aspen Insurance Holdings Limited (AHL) stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to stock market and economic condition keep tight stop loss on all position. You can buy this stock near $22.93 UPDATE - Aspen Insurance Q2 oper profit beats estimates (at Reuters) (Wed, 28 Jul 2010 21:11:11 Etc/GMT) ASPEN INSURANCE HOLDINGS LTD Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements (EDGAR Online) (Wed, 28 Jul 2010 20:49:51 Etc/GMT) Aspen Insurance Holdings Reports Results for Second Quarter and First Half of 2010 (Business Wire) (Wed, 28 Jul 2010 20:32:00 Etc/GMT) HAMILTON, Bermuda----Aspen Insurance Holdings Limited today reported net income after tax for the second quarter of 2010 of $108.9 million and operating earnings of $1.23 per diluted ordinary share. Aspen Declares Dividends on Ordinary Shares, Perpetual PIERS and Perpetual Preference Shares (Business Wire) (Wed, 28 Jul 2010 16:37:00 Etc/GMT) HAMILTON, Bermuda----Aspen Insurance Holdings Limited today announced that its Board of Directors declared a quarterly cash dividend on its ordinary shares of US$0.15 per ordinary share. Q2 2010 Aspen Insurance Holdings Limited Earnings Release - After Market Close (CCBN) (Wed, 28 Jul 2010 11:07:25 Etc/GMT)
CBST	CUBIST PHARMACEUTICALS INC COM
Sector Biotechnology & Drugs Recommendations Buy Buy Near 23.54 Stop Loss 17.82 Posted Date 11/2/2008 12:00:00 AM First Resistance 25.55 Second Resistance 26.77 Third Resistance   First Support 23.34 Second Support 17.82 Comments 11/2/2008 9:05:00 PM Biotechnology company Cubist Pharmaceuticals Inc.com (CBST) stock given a breakout on 10/31/08 with good volume again many technical indicators also have given a buy signal, with rising moving average. Stochastic and ADX also given a buy signal. Cubist Pharmaceuticals Inc.com (CBST) announced on 10/16/08 its third-quarter profit jumped 40 percent and Revenue increased 41 percent. Cubist Pharmaceuticals Inc.com (CBST) is a drug discovery company. As per technical analysis, stock analysis and fundamentally this stock looks good candidate for portfolio investment. Cubist Pharmaceuticals Inc.com stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to stock market and economic condition keep tight stop loss on all position. You can buy this stock near $23.54 $500 Million+ In Annual Sales And Growing, Cubist Pharmaceuticals (CBST) Top Stock Pick By Industry Analyst At RBC Capital Markets (Wall Street Transcript) (Mon, 19 Jul 2010 20:37:00 Etc/GMT) 67 WALL STREET, New York - July 19, 2010 - The Wall Street Transcript has recently published its Biotechnology & Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. This special feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online. Cubist Pharmaceuticals, Inc. (CBST) to Ring The NASDAQ Stock Market Opening Bell (GlobeNewswire) (Mon, 19 Jul 2010 13:50:34 Etc/GMT) ADVISORY -- What: Cubist Tops, Riding on Cubicin (Zacks) (Fri, 16 Jul 2010 17:46:41 Etc/GMT) On a reported basis, the company earned 45 cents per share as against 40 cents per share in the year-ago quarter. New Star Analyst Rankings for Cubist Pharmaceuticals, Inc. (StarMine) (Fri, 16 Jul 2010 15:39:18 Etc/GMT) Cubist 2Q profit rises on antibiotic sales (AP) (Thu, 15 Jul 2010 21:38:47 Etc/GMT) Cubist Pharmaceuticals Inc. said Thursday that its profit grew 18 percent in the second quarter as sales of its antibiotic Cubicin improved.
PETS	PETMED EXPRESS INC COM
Sector Retail (Drugs) Recommendations Buy Buy Near 16.00 Stop Loss 14.20 Posted Date 11/2/2008 12:00:00 AM First Resistance 17.72 Second Resistance 19.50 Third Resistance   First Support 15.97 Second Support 14.20 Comments 11/2/2008 9:06:46 PM PetMed Express Inc.com (PETS) stock has given a buy signal, with rising moving average. Stochastic and ADX also given a buy signal. PetMed Express Inc.com (PETS) announced on 10/20/08 its fiscal second-quarter profit climbed 29 percent PetMed Express Inc.com (PETS) is a pet-medication delivery company. As per technical analysis, stock analysis and fundamentally this stock looks good candidate for portfolio investment. PetMed Express Inc.com stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to stock market and economic condition keep tight stop loss on all position. You can buy this stock near $16.00 4 Significant Earnings Results: eBay, Netflix, Amazon and PetMed Express (at Seeking Alpha) (Sun, 25 Jul 2010 16:17:21 Etc/GMT) The Rest Of The Disappointing Story (at Investopedia) (Fri, 23 Jul 2010 21:40:01 Etc/GMT) Disappointing Quarter for PetMed (Zacks) (Tue, 20 Jul 2010 16:56:00 Etc/GMT) PetMed Express Q1 earnings fall 11% (at bizjournals.com) (Tue, 20 Jul 2010 15:05:06 Etc/GMT) New Star Analyst Rankings for PetMed Express, Inc. (StarMine) (Tue, 20 Jul 2010 13:25:49 Etc/GMT)
WSBC	WESBANCO INC COM
Sector Financial Recommendations Buy Buy Near 27.18 Stop Loss 25.46 Posted Date 11/2/2008 12:00:00 AM First Resistance 28.90 Second Resistance 30.00 Third Resistance 31.45 First Support 25.46 Second Support 22.56 Comments 11/2/2008 9:07:49 PM WesBanco, Inc. com (WSBC) stock has given a buy signal, with rising moving average. Stochastic and ADX also given a buy signal. WesBanco, Inc. com (WSBC) announced on 10/21/08 its net income increased 17.9% during the third quarter of 2008 WesBanco, Inc. com (WSBC) is a multi-state bank holding company. As per technical analysis, stock analysis and fundamentally this stock looks good candidate for portfolio investment. WesBanco, Inc. com stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to stock market and economic condition keep tight stop loss on all position. You can buy this stock near $27.18 WESBANCO INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online) (Mon, 26 Jul 2010 20:29:32 Etc/GMT) WesBanco Announces Improved Second Quarter 2010 Results (PR Newswire) (Mon, 26 Jul 2010 20:11:00 Etc/GMT) Paul M. Limbert, President and Chief Executive Officer of WesBanco, Inc. , a Wheeling, West Virginia based multi-state bank holding company, today announced earnings for the second quarter and year-to-date periods ended June 30, 2010. Q2 2010 Wesbanco Earnings Release - After Market Close (CCBN) (Mon, 26 Jul 2010 11:07:17 Etc/GMT) [video] Five Banks with the Highest APR Rates (at TheStreet.com) (Sun, 4 Jul 2010 16:22:00 Etc/GMT) WESBANCO INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online) (Tue, 15 Jun 2010 12:59:00 Etc/GMT)
AMED	AMEDISYS INC COM
Sector Healthcare Recommendations Buy Buy Near 55.13 Stop Loss 46.55 Posted Date 11/2/2008 12:00:00 AM First Resistance 65.08 Second Resistance 67.29 Third Resistance   First Support 55.03 Second Support 46.55 Comments 11/2/2008 9:08:49 PM Amedisys Inc. com (AMED) stock has given a buy signal, with rising moving average. Stochastic and ADX also given a buy signal. Amedisys Inc. com (AMED) announced on 10/28/08 its profit grew 16 percent in the third quarter, and revenue jumped 78 percent. The company reported stronger admissions growth, and it was operating 150 more health agencies than a year earlier and also raised its full-year estimates, predicting greater profit and revenue Amedisys Inc. com (AMED) is a Home nursing company. As per technical analysis, stock analysis and fundamentally this stock looks good candidate for portfolio investment. Amedisys Inc. com stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to stock market and economic condition keep tight stop loss on all position. You can buy this stock near $55.13 Screening for Value Stocks With High Growth Potential (at Seeking Alpha) (Thu, 29 Jul 2010 08:50:52 Etc/GMT) Berman DeValerio Files Securities Class Action Against Amedisys, Inc. (Business Wire) (Wed, 28 Jul 2010 23:04:00 Etc/GMT) BATON ROUGE, La.----The law firm of Berman DeValerio filed a securities fraud lawsuit today against Amedisys, Inc. and certain of its top officials. Nasdaq stocks posting largest percentage increases (AP) (Tue, 27 Jul 2010 22:01:15 Etc/GMT) AMEDISYS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (EDGAR Online) (Tue, 27 Jul 2010 20:23:45 Etc/GMT) The Pomerantz Firm Reminds Amedisys, Inc. Investors of Class Action Lawsuit -- AMED (GlobeNewswire) (Mon, 26 Jul 2010 21:12:52 Etc/GMT) NEW YORK -- Pomerantz Haudek Grossman & Gross LLP reminds investors that a class action lawsuit was filed in the United States District Court, Middle District of Louisiana against Amedisys, Inc. and certain of its top officials.